Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications

Recruiting now

Conditions studied: Preeclampsia, Preterm Birth, Pregnancy Complications, Fetal Anomalies

In brief

The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.

Key facts

Study ID

NCT02744365

Run by

CHU de Quebec-Universite Laval

People needed

7845

Starts

2015-04-01

Expected to finish

2028-04-01

Last updated by the study team

2022-03-16

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• (specific to each study)

You may not qualify if…

• pregnant women <18 years old at recruitment
• negative fetal heart at recruitment
• women not able to provide an informed consent to the study

Where it is running

• CHU de Quebec — Québec, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.